NASDAQ:MRNA Archives - BioPharmaJournal

Moderna Inc. (NASDAQ: MRNA) Announce Phase 2 EPICCURE Study Results Evaluating...

Kate Hudson - November 30, 2021 0

Approval Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine In Teenagers Delayed Because...

Gavins Felicity - October 22, 2021 0

Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine Booster Under EU Review

Gavins Felicity - October 6, 2021 0

Indian Government Will Not Purchase the Pfizer Inc. (NYSE: PFE) and...

Gavins Felicity - September 27, 2021 0

Moderna Inc. (NASDAQ: MRNA) Receives New Drug Submission Approval From Health...

Gavins Felicity - September 20, 2021 0

Moderna (NASDAQ: MRNA) Reveals Plans to Create A Combined Coronavirus and...

Kate Hudson - September 13, 2021 0

Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine...

Gavins Felicity - September 6, 2021 0

Moderna Inc. (NASDAQ: MRNA) Vaccine Distribution Suspended In Japan Following Contamination...

Gavins Felicity - August 30, 2021 0

Moderna Inc.’s (NASDAQ: MRNA) and Sinopharm Group Co Vaccines Receive Emergency...

Ward Sport - August 24, 2021 0

Autolus Therapeutics PLC (NASDAQ: AUTL) Signs New Deal With Moderna Inc...

Gavins Felicity - August 9, 2021 0

12 3 4 Page 1 of 4

Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...

Kate Hudson - August 5, 2022 0

Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...

IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...

August 4, 2022

Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...

August 3, 2022

Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study...

August 2, 2022

Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A....

August 1, 2022

Tag: NASDAQ:MRNA

Recent Post